These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 5129037

  • 1. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R, Renda A.
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract] [Full Text] [Related]

  • 2. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F.
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract] [Full Text] [Related]

  • 4. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E, Rozov H.
    Bibl Anat; 1973 Oct; 11():334-9. PubMed ID: 4789059
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C.
    Phlebologie; 1969 Oct; 22(1):105-11. PubMed ID: 5775643
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the cardiovascular dynamic changes induced by chorionic gonadotropin in vascular diseases].
    Melloni G, Fassini G.
    Minerva Med; 1971 Mar 28; 62(25):1297-318. PubMed ID: 5552473
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A.
    Atti Soc Ital Cardiol; 1969 Jan 21; 2():251-60. PubMed ID: 5406537
    [No Abstract] [Full Text] [Related]

  • 12. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
    Raso AM, Silvestrini P.
    Minerva Med; 1973 Mar 29; 64(19):961-9. PubMed ID: 4703313
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC, Fumagalli G, Locatelli R.
    Arch Patol Clin Med; 1965 Jun 29; 41(6):479-83. PubMed ID: 5319767
    [No Abstract] [Full Text] [Related]

  • 19. [Xanthinol-nicotinate (complamine)].
    Cas Lek Cesk; 1968 Jun 29; 107(51):1567-8. PubMed ID: 5700857
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.